關於「ACCORD trial」標籤，搜尋引擎有相關的訊息討論：

Effects of Intensive Glucose Lowering in Type 2 Diabetes | NEJM。

2008年6月12日 · In this randomized study, 10,251 patients (mean age, 62.2 years) with a median glycated hemoglobin level of 8.1% were assigned to receive ...： tw | tw。

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus。

2010年4月29日 · Background There is no evidence from randomized trials to support a strategy of lowering systolic blood pressure ... The ACCORD Study Group.： tw | tw。

Clinical Implications of the ACCORD Trial。

2012年1月1日 · The ACCORD study was a maximum effort to determine whether treating ... FL. 2010. Glycated hemoglobin, diabetes, and cardiovascular risk in ...： 。

Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on ...。

2015年12月22日 · The design of the ACCORD trial and the effect of intensive versus standard ... FL), GlaxoSmithKline Pharmaceuticals (Philadelphia, PA), ...。

Effects of Randomization to Intensive Glucose Control on Adverse ...。

2013年10月19日 · The ACCORD trial was a randomized, multicenter, double 2 × 2 factorial trial designed to test the effects on major cardiovascular disease (CVD) ...： tw | tw。

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular ...。

The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was designed to determine whether a strategy of targeting normal glycated hemoglobin ...： tw | tw。

Action to Control Cardiovascular Risk in Diabetes (ACCORD)。

Click here for the ACCORD trial web site This link exits the ClinicalTrials.gov site ... Largay J, McDonald C, Lochnan HA, Booth GL; ACCORD Study Group.： tw | tw。

Effects of Intensive Blood Pressure Control in the Management of ...。

2010年8月24日 · To appreciate the importance of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one needs to remember that the ...： tw | tw。

Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury。

2018年10月2日 · Among a subset of ACCORD-BP trial participants, intensive BP control was associated with reductions in eGFRs, but not with an increase in ...。

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial。

A fuller discussion of the rationale for conducting the ACCORD trial is presented ... Inc. (Tequesta, FL); GlaxoSmithKline Pharmaceuticals (Philadelphia, ...